Clinical Trial Update: Concurrent Xeloda and Radiotherapy for Bone Metastases [Phase 2]

View source ↗

Summary

The update concerns a Phase 2 trial evaluating the combination of Xeloda (capecitabine) with radiotherapy for bone metastases in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Solid Tumors, Bone Metastases | Phase 2 | Status: UNKNOWN